The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer
Open accessAbstract
Breast cancer remains a major cause of death in the United States as well as the rest of the world. In view of the limited treatment options for patients with advanced breast cancer, preventive and novel therapeutic approaches play an important role in combating this disease. The plant-derived triterpenoids, commonly used for medicinal purposes in many Asian countries, posses various pharmacological properties. A large number of triterpenoids are known to exhibit cytotoxicity against a variety of tumor cells as well as anticancer efficacy in preclinical animal models. Numerous triterpenoids have been synthesized by structural modification of natural compounds. Some of these analogs are considered to be the most potent antiinflammatory and anticarcinogenic triterpenoids known. This review examines the potential role of natural triterpenoids and their derivatives in the chemoprevention and treatment of mammary tumors. Both in vitro and in vivo effects of these agents and related molecular mechanisms are presented. Potential challenges and future directions involved in the advancement of these promising compounds in the prevention and therapy of human breast cancer are also identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Sung, B., Park, B., Yadav, V. R., & Aggarwal, B. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090209 · Cited by 123
RetractedLavhale, M. S., Kumar, S., Mishra, S. H., & Sitasawad, S. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005365 · Cited by 45
RetractedSlamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“These findings suggest that CDDO could be beneficial for therapy of patients with HER2overexpressing breast cancer, an aggressive form of disease characterized by significantly reduced survival times (105).”
BackgroundGlossary of Indian Medicinal Plants
Chopra, R. N., Nayar, S. L., & Chopra, I. (1956) · Cited by 5,994
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 1×
“Accumulating evidence indicates that constitutively activated, tyrosine-phosphorylated signal transducer and activators of transcription 3 (STAT3) plays a vital role in several human malignancies including breast cancer (38, 39).”
BackgroundThe Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Pisha, E., Chai, H., Lee, I.-S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W. W., Fong, H. H. S., Kinghorn, A. D., Brown, D. M., et al. (1995) · Nature Medicine · doi:10.1038/nm1095-1046 · Cited by 886
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 643
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer
Liby, K. T., Yore, M. M., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2129 · Cited by 637 · cited 3×
“The use of triterpenoids and related compounds for either chemoprevention or therapy of mammary carcinoma has not been extensively discussed previously although several excellent articles provide an overview of the antitumor potential of these agents against various cancers (24-27).”
BackgroundCucurbitacins and cucurbitane glycosides: structures and biological activities
Chen, J. C., Chiu, M. H., Nie, R. L., Cordell, G. A., & Qiu, S. X. (2005) · Natural Product Reports · doi:10.1039/b418841c · Cited by 635
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Bishayee, A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0160 · Cited by 528
Self-citationBreast Cancer Facts and Figures 2000
(2000) · Cancer Practice · doi:10.1046/j.1523-5394.2000.82001.x · Cited by 508
Pentacyclic Triterpenes of the Lupane, Oleanane and Ursane Group as Tools in Cancer Therapy
Laszczyk, M. (2009) · Planta Medica · doi:10.1055/s-0029-1186102 · Cited by 489
Targeting NOX, iNOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals
Murakami, A., & Ohigashi, H. (2007) · International Journal of Cancer · doi:10.1002/ijc.23161 · Cited by 478
Sporn, M. B., & Suh, N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.525 · Cited by 439
Biosynthetic diversity in plant triterpene cyclization
Phillips, D. R., Rasbery, J. M., Bartel, B., & Matsuda, S. P. (2006) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2006.03.004 · Cited by 390
Triterpenoids as new promising anticancer drugs
Petronelli, A., Pannitteri, G., & Testa, U. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328330fd90 · Cited by 381
Chemopreventive effects of natural dietary compounds on cancer development
Pan, M.-H., & Ho, C.-T. (2008) · Chemical Society Reviews · doi:10.1039/b801558a · Cited by 346
He, X., & Liu, R. H. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf063563o · Cited by 301
Biosynthesis and engineering of isoprenoid small molecules
Withers, S. T., & Keasling, J. D. (2007) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0593-1 · Cited by 300
Cranberry and Its Phytochemicals: A Review of In Vitro Anticancer Studies
Neto, C. C. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.1.186s · Cited by 294
Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana
Jayaprakasam, B., Seeram, N. P., & Nair, M. G. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00497-4 · Cited by 291
The Pharmacology of Chinese Herbs
Chan, K. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03767.x · Cited by 290
Molecular targets for breast cancer therapy and prevention
Bange, J., Zwick, E., & Ullrich, A. (2001) · Nature Medicine · doi:10.1038/87872 · Cited by 288
Cancer Chemopreventive Potential of Apples, Apple Juice, and Apple Components
Gerhauser, C. (2008) · Planta Medica · doi:10.1055/s-0028-1088300 · Cited by 288
Suh, N., Wang, Y., Honda, T., Gribble, G. W., Dmitrovsky, E., Hickey, W. F., Maue, R. A., Place, A. E., Porter, D. M., Spinella, M. J., et al. (1999) · PubMed · Cited by 282
Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity
Sun, J., Blaskovich, M. A., Jove, R., Livingston, S. K., Coppola, D., & Sebti, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208470 · Cited by 263
Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview.
Ovesná, Z., Vachálková, A., Horváthová, K., & Tóthová, D. (2004) · PubMed · Cited by 251
Terpenoids and breast cancer chemoprevention
Rabi, T., & Bishayee, A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0118-y · Cited by 235
Self-citationHsu, Y.-L., Kuo, P.-L., Lin, L.-T., & Lin, C.-C. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078808 · Cited by 228
Vanadium in the detection, prevention and treatment of cancer: The in vivo evidence
Bishayee, A., Waghray, A., Patel, M. A., & Chatterjee, M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.030 · Cited by 222
Self-citationOleanolic acid and related derivatives as medicinally important compounds
Sultana, N., & Ata, A. (2008) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701633187 · Cited by 211
Boswellic acids: a group of medicinally important compounds
Shah, B. A., Qazi, G. N., & Taneja, S. C. (2009) · Nat. Prod. Rep. · doi:10.1039/b809437n · Cited by 209
Chemoprevention of breast cancer with selective oestrogen-receptor modulators
Jordan, V. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2048 · Cited by 206
Betulinic acid, a natural compound with potent anticancer effects
Mullauer, F. B., Kessler, J. H., & Medema, J. P. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283357c62 · Cited by 198
Singletary, K., MacDonald, C., & Wallig, M. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04227-9 · Cited by 193
Kessler, J. H., Mullauer, F. B., de Roo, G. M., & Medema, J. P. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.11.003 · Cited by 188
Plant-Derived Triterpenoids as Potential Antineoplastic Agents
Setzer, W., & Setzer, M. (2003) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557033487854 · Cited by 186
Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells.
Subbaramaiah, K., Michaluart, P., Sporn, M. B., & Dannenberg, A. J. (2000) · PubMed · Cited by 174
Place, A. E., Suh, N., Williams, C. R., Risingsong, R., Honda, T., Honda, Y., Gribble, G. W., Leesnitzer, L. M., Stimmel, J. B., Willson, T. M., et al. (2003) · PubMed · Cited by 149
He, X., & Liu, R. H. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf061058l · Cited by 148
Rzeski, W., Stepulak, A., Szymański, M., Sifringer, M., Kaczor, J., Wejksza, K., Zdzisińska, B., & Kandefer‐Szerszeń, M. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0090-1 · Cited by 147
Lapillonne, H., Konopleva, M. Y., Tsao, T., Gold, D. L., McQueen, T. J., Sutherland, R. L., Madden, T. L., & Andreeff, M. (2003) · PubMed · Cited by 144
Sutherland, S., Ashley, S. E., Miles, D. W., Chan, S. Y. T., Wardley, A. M., Davidson, N. G. P., Bhatti, R., Shehata, M., Nouras, H., Camburn, T., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605586 · Cited by 140
The epidermal growth factor receptor as a target for therapy in breast carcinoma
Baselga, J. M., & Mendelsohn, J. M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666188 · Cited by 133
Wu, C., Chan, M.-L., Chen, W.-Y., Tsai, C., Chang, F., & Wu, Y. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0027 · Cited by 132
Hyer, M. L., Croxton, R., Krajewska, M., Krajewski, S., Kress, C. L., Lü, M., Suh, N., Sporn, M. B., Cryns, V. L., Zapata, J. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3319 · Cited by 132
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo
Wakimoto, N., Yin, D., O’Kelly, J., Haritunians, T., Karlan, B. Y., SAID, J. W., Xing, H., & Koeffler, H. P. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00899.x · Cited by 127
Ursolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells
Kassi, E. N., Sourlingas, T. G., Spiliotaki, M., Papoutsi, Z., Pratsinis, H., Aligiannis, N., & Moutsatsou, P. (2009) · Cancer Investigation · doi:10.1080/07357900802672712 · Cited by 125
Yeh, C., Wu, C., & Yen, G. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900414 · Cited by 124
SERMs: Meeting the Promise of Multifunctional Medicines
Jordan, V. C. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk062 · Cited by 123
Ahmad, R., Raina, D., Meyer, C., & Kufe, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3036 · Cited by 120 · cited 1×
“block the janus-activated kinase-1 (JAK1)→STAT3 pathway by directly inhibiting both JAK1 and STAT3 leading to suppression of growth and survival genes (80, 81).”
BackgroundIsoprenoid biosynthetic pathways as anti-infective drug targets
Rohdich, F., Bacher, A., & Eisenreich, W. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330785 · Cited by 112
Idris, A. I., Libouban, H., Nyangoga, H., Landao‐Bassonga, E., Chappard, D., & Ralston, S. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0133 · Cited by 112
Ling, X., Konopleva, M. Y., Zeng, Z., Ruvolo, V. R., Stephens, L. C., Schober, W. D., McQueen, T. J., Dietrich, M. F., Madden, T. L., & Andreeff, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3629 · Cited by 90
Betulin Elicits Anti‐Cancer Effects in Tumour Primary Cultures and Cell LinesIn Vitro
Rzeski, W., Stepulak, A., Szymański, M., Juszczak, M., Grabarska, A., Sifringer, M., Kaczor, J., & Kandefer‐Szerszeń, M. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00471.x · Cited by 85
Yang, L., Wu, S., Zhang, Q., Liu, F., & Wu, P. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.06.018 · Cited by 83
Liby, K. T., Risingsong, R., Royce, D. B., Williams, C. R., Yore, M. M., Honda, T., Gribble, G. W., Lamph, W. W., Vannini, N., Sogno, I., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0040 · Cited by 77
Duan, Z., Ames, R. Y., Ryan, M. B., Hornicek, F. J., Mankin, H. J., & Seiden, M. V. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0785-8 · Cited by 75
Antioxidant Activity, Cytotoxicity, and DNA Information of Glossogyne tenuifolia
Hsu, H.-F., Houng, J.-Y., Chang, C.-L., Wu, C., Chang, F., & Wu, Y. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050463u · Cited by 70
Korkina, L. G., Luca, C. D., Kostyuk, V. A., & Pastore, S. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789352312 · Cited by 70
Konopleva, M. Y., Zhang, W., Shi, Y.-X., McQueen, T. J., Tsao, T., Abdelrahim, M., Munsell, M. F., Johansen, M. J., Yu, D., Madden, T. L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0350 · Cited by 70
Amico, V., Barresi, V., Condorelli, D. F., Spatafora, C., & Tringali, C. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf052812q · Cited by 68
The cardiac safety of trastuzumab in the treatment of breast cancer
Chien, A. J., & Rugo, H. S. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740331003627441 · Cited by 62
Honda, T., Janosik, T., Honda, Y., Han, J., Liby, K. T., Williams, C. R., Couch, R. D., Anderson, A. C., Sporn, M. B., & Gribble, G. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049727e · Cited by 56
Guo, M., Zhang, S., Song, F., Wang, D. W., Liu, Z., & Liu, S. (2003) · Journal of Mass Spectrometry · doi:10.1002/jms.486 · Cited by 50
Natural Products for Chemopreventive and Adjunctive Therapy in Oncologic Disease
Dennis, T., Fanous, M. J., & Mousa, S. A. (2009) · Nutrition and Cancer · doi:10.1080/01635580902825530 · Cited by 49
Novel Drug Amooranin Induces Apoptosis Through Caspase Activity in Human Breast Carcinoma Cell Lines
Rabi, T., Ramachandran, C., Fonseca, H. B., Nair, R. P. K., Alamo, A., Melnick, S. J., & Escalon, E. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024911925623 · Cited by 44
Yoon, H., & Liu, R. H. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8012844 · Cited by 43
Cytotoxic Triterpenoids from the Leaves ofEuphorbia pulcherrima
Smith-Kielland, I., Dornish, J. M., Malterud, K., Hvistendahl, G., Rømming, C., Bøckmann, O., Kolsaker, P., Stenstrøm, Y., & Nordal, A. (1996) · Planta Medica · doi:10.1055/s-2006-957893 · Cited by 43
Basu, S. C., Ma, R., Boyle, P. J., Mikulla, B., Bradley, M., Smith, B. L., Basu, M., & Banerjee, S. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000043293.46845.07 · Cited by 40
Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes
Oviedo-Chávez, I., Apan, T. R., & Martínez‐Vázquez, M. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.9.0003 · Cited by 38
Chemoprevention of breast cancer
Castrellon, A. B., & Glück, S. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.3.443 · Cited by 33
Rabi, T., Wang, L., & Banerjee, S. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9275-z · Cited by 31
Importance of local tumour control in breast cancer
Wong, J. S., & Harris, J. R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00190-x · Cited by 28
Cytotoxic activities of chemical constituents from Mesua daphnifolia.
Ee, G. C. L., Lim, C. K., Rahmat, A. B., & Lee, H.-S. (2005) · PubMed · Cited by 26
Chemoprevention Strategies 2006
Vogel, V. G. (2007) · Current Treatment Options in Oncology · doi:10.1007/s11864-007-0019-z · Cited by 22
Chemoprevention of breast cancer: current status and future prospects
Zhao, X., Li, L., & Wang, Z. (2006) · Frontiers in bioscience · doi:10.2741/1967 · Cited by 16
Cited by
Wang, H., Oo Khor, T., Shu, L., Su, Z.-Y., Fuentes, F., Lee, J.-H., & Tony Kong, A.-N. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012803833026 · Cited by 529
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Kashyap, D., Tuli, H. S., Yerer, M. B., Sharma, A., Sak, K., Srivastava, S., Pandey, A., Garg, V. K., Sethi, G., & Bishayee, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.014 · Cited by 390
Self-citationCannabis Pharmacology: The Usual Suspects and a Few Promising Leads
Russo, E. B., & Marcu, J. (2017) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.03.004 · Cited by 368
Terpenoids as potential chemopreventive and therapeutic agents in liver cancer
Thoppil, R. J. (2011) · World Journal of Hepatology · doi:10.4254/wjh.v3.i9.228 · Cited by 353
Metadata
- Authors
- Bishayee, A.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2011
- Volume
- 16
- Issue
- 1
- Pages
- 980
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/3730
- OpenAlex
- W1996023050
- Cited by
- 330
- References
- 81
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.